2019-2021年中国癌症存活率统计:一个多中心,基于人口的研究
Hongmei Zeng1, Rongshou Zheng1, Kexin Sun1
1National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Journal of the National Cancer Center
|September 16, 2024
概括
中国中国中国中国.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 健康中国计划旨在提高癌症存活率.
- 2022年癌症5年生存率的目标是所有癌症组合的43.3%.
- 本研究评估了实现国家癌症控制目标的进展情况.
研究的目的:
- 评估中国所有癌症和25种特定癌症的5年相对存活率.
- 分析2019年至2021年的生存趋势.
- 为了确定癌症控制方面的进展.
主要方法:
- 利用了来自中国32个省级地区6,410,940名癌症患者的数据 (2008-2019年诊断).
- 雇佣了用于癌症登记的标准化数据收集和质量控制.
- 使用国际癌症生存标准重量估计的年龄标准化的5年相对存活率.
主要成果:
- 所有癌症的5年相对生存率在2019-2021年总和达到43.7%.
- 根据癌症类型的生存率有很大的不同,从8.5% (胰腺) 到92.9% (甲状腺).
- 从2008年到2021年,在肺癌,前列腺癌,乳腺癌和膀癌等方面,观察到显著的生存率改善.
结论:
- 在中国,癌症控制进展显而易见,超过了2022年生存目标.
- 综合性战略对于癌症预防和控制的持续进展至关重要.
- 生存率主要因癌症类型和性别而异.
更多相关视频
07:49Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
117
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Actuarial Approach
68
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
68
